tapentadol

(redirected from Nucynta ER)
Also found in: Medical.
Related to Nucynta ER: Tapentadol
Translations

tapentadol

n tapentadol m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
The judgment disregards the Company's compliance with federal and state laws, the unique role its medicines play in the lives of the people who need them, its responsible marketing practices and that since launch, DURAGESIC, NUCYNTA and NUCYNTA ER have accounted for less than one percent of total opioid prescriptions in Oklahoma as well as the United States.
The company said it is "confident it has strong grounds to appeal this decision," adding that "the judgment disregards the company's compliance with federal and state laws, the unique role its medicines play in the lives of the people who need them, its responsible marketing practices and that since launch, Duragesic, Nucynta and Nucynta ER have accounted for less than one percent of total opioid prescriptions in Oklahoma as well as the United States." Michael Ullmann, executive VP, General Counsel, Johnson & Johnson, said, "Janssen did not cause the opioid crisis in Oklahoma, and neither the facts nor the law support this outcome.
The state of New Jersey has filed a five-count lawsuit against Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, for deceiving consumers about the dangers of two of its opioid products with high potential for abuse - Nucynta and Nucynta ER, Attorney General Gurbir Grewal said Tuesday.The state of New Jersey has filed a five-count lawsuit against Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, for deceiving consumers about the dangers of two of its opioid products with high potential for abuse Nucynta and Nucynta ER, Attorney General Gurbir Grewal said Tuesday.
The franchise covers Nucynta (tapentadol), Nucynta ER (tapentadol) extended-release tablets and Nucynta (tapentadol) oral solution.
The Nucynta franchise includes Nucynta ER (tapentadol) extended release tablets indicated for the management of pain, including neuropathic pain associated with diabetic peripheral neuropathy, severe enough to require daily, around-the-clock, long-term opioid treatment, and Nucynta (tapentadol), an immediate release version of tapentadol, for management of moderate to severe acute pain in adults.
said last month it received regulatory approval for a wider use of its Nucynta ER painkiller, for pain from nerve damage that is brought on by diabetes.
M2 EQUITYBITES-January 19, 2015-Janssen Pharmaceuticals to sell US license rights to NUCYNTA, NUCYNTA ER and NUCYNTA Oral Solution for USD1.05bn
M2 PHARMA-January 19, 2015-Janssen Pharmaceuticals to sell US license rights to NUCYNTA, NUCYNTA ER and NUCYNTA Oral Solution for USD1.05bn
With the Court's ruling, the company expects market exclusivity until December 2025 for NUCYNTA ER, NUCYNTA and NUCYNTA oral solution.
As part of the agreement, Depomed will receive an upfront payment of USD10m, a low single digit royalty on net sales of NUCYNTA ER (tapentadol extended-release tablets) in the US, Canada and Japan from and after 2 July 2012 through 31 December 2021 and a one-time sales milestone on specified quarterly net sales.
These statements involve inherent risks and uncertainties that could cause actual results to differ materially from those projected or anticipated, including risks related to regulatory approval and clinical development of long-acting cosyntropin, expectations regarding royalties to be received based on sales of NUCYNTA and NUCYNTA ER, expectations regarding potential business opportunities and other risks outlined in the Company's public filings with the Securities and Exchange Commission, including the Company's most recent annual report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.